Madrigal pharmaceuticals, inc. (MDGL)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
License and milestone revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,302

1,143

1,143

1,143

1,143

1,143

Cost sharing reimbursements, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,240

2,217

Total collaboration revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,302

1,143

1,143

1,143

3,383

3,360

Grant revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

147

121

521

211

-

-

-

Total revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

147

3,423

1,664

1,354

1,143

3,383

3,360

Operating expenses:
Research and development

33,400

24,910

19,447

15,594

12,373

8,871

6,211

5,109

5,198

6,512

6,682

6,816

4,380

5,523

7,806

2,088

516

7,246

682

16,377

16,182

15,653

16,208

18,761

17,583

19,981

17,623

17,876

16,380

14,351

11,743

11,252

12,066

10,859

10,751

10,417

9,436

11,023

9,688

General and administrative

4,605

5,044

4,748

7,110

5,746

5,583

5,122

2,717

1,871

2,399

1,955

1,623

1,695

2,232

6,285

551

222

3,134

197

3,127

4,150

4,241

3,241

2,940

5,324

3,463

4,171

4,187

3,878

3,352

2,796

2,882

2,646

2,803

3,131

2,946

2,673

2,591

2,716

Total operating expenses

38,005

29,954

24,195

22,704

18,119

14,454

11,333

7,826

7,069

8,911

8,637

8,439

6,075

7,755

14,091

2,639

738

10,380

880

19,504

20,332

19,894

19,449

21,701

22,907

23,444

21,794

22,063

20,258

17,703

14,539

14,134

14,712

13,662

13,882

13,363

12,109

13,614

12,404

Loss from operations

-38,005

-29,954

-24,195

-22,704

-18,119

-14,454

-11,333

-7,826

-7,069

-8,911

-8,637

-8,439

-6,075

-7,755

-14,091

-2,639

-738

-10,380

-880

-19,504

-20,332

-19,894

-19,449

-21,701

-22,907

-23,444

-21,794

-22,063

-20,258

-17,703

-14,539

-14,134

-14,565

-10,239

-12,218

-12,009

-10,966

-10,231

-9,044

Interest income (expense), net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-156

-919

-296

-375

-458

-517

-585

-650

-718

-721

-724

-470

-420

-457

-486

-486

-504

-516

-493

-435

-31

-30

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

238

975

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

1,870

2,214

2,766

3,005

3,039

-

-

-

-

-

-

-

-

-

42

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income

-

-

-

-

-

-

-

200

-

250

100

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-36,100

-27,740

-21,429

-19,699

-15,080

-11,475

-8,512

-6,460

-6,364

-8,445

-8,363

-8,347

-5,999

-7,749

-14,049

-2,877

-1,713

-10,536

-1,799

-19,800

-20,707

-20,352

-19,966

-22,286

-23,557

-24,162

-22,515

-22,787

-20,728

-18,123

-14,996

-14,620

-15,051

-10,743

-12,734

-12,502

-11,401

-10,262

-9,074

Net loss per common share:
Basic and diluted net loss per common share (in dollars per share)

-2.34

-1.80

-1.39

-1.28

-0.98

-0.75

-0.56

-0.45

-0.45

-0.67

-0.68

-0.69

-0.50

22.57

-1.59

-16.33

-9.72

-0.08

-10.46

-0.15

-0.19

-0.19

-0.19

-0.24

-0.28

-0.31

-0.33

-0.33

-0.30

-0.29

-0.25

-0.25

-0.27

-0.22

-0.26

-0.26

-0.27

-0.25

-0.22

Basic and diluted weighted average number of common shares outstanding

15,429

15,429

15,415

15,368

15,364

15,348

15,307

14,383

14,127

12,597

12,378

12,039

11,955

11,619

8,847

176

176

137,336

172

132,295

108,376

108,366

105,774

94,046

85,438

76,769

69,047

69,034

68,991

62,966

60,661

57,650

56,366

49,426

49,403

47,845

42,008

-

-

Basic weighted average number of common shares outstanding (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

40,382

40,342

Diluted weighted average number of common shares outstanding (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

40,382

40,342